Scientific Publications & Original Research
Exploring over two decades of peer-reviewed literature, international consensus recommendations, digital health breakthroughs, and clinical trials in diabetology.
Articles
Categories
Research
SWEET / RSSDI
Effectiveness of Telemedicine plus Conventional Care vs. Conventional Care Alone in Reducing Complications of Diabetes—A Pilot Study
Jothydev Kesavadev, 84TH ADA Annual Conference (ADA 2024), Orlando, FL- June 21-24, Oral Presentation
25 years of telemedicine Vs conventional care in diabetes: assessing vascular complications and quality of life
Jothydev Kesavadev, 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2024), Florence & Online, Italy, 6-9 March 2024. Invited Lecture
Reducing the Cost of Diabetes Care with Telemedicine, Smartphone, and Home Monitoring.
Kesavadev, J., Mohan, V. J Indian Inst Sci. 2023 Apr 2023.
Merits And Demerits Of Using Telemedicine Based Program For Diabetes Management.
Kesavadev J, Saboo B, Jothydev K, Shankar A, Krishnan G, Lally J, Sanal G, Rajalakshmi S, Jothydev S. IDF World Diabetes Congress 2022, Lisbon and online. Dec 5-8, 2022. e-poster
Impact of Webinars and Telemedicine during COVID-19 Lockdown in Transforming Outcomes in 848 T2D Patients in India.
Kesavadev J, Shankar A, Krishnan G, Basanth A, Jothydev K, Chandran B, S. S, Jothydev S. ADA, 81ST Scientific Sessions, Virtual, June 25-29, 2021. 468-P
Comparing Telemedicine with Conventional Diabetes Care in Assessing Long-Term Outcomes in 451 Patients over 15 Years.
Kesavadev J, Shankar A, Krishnan G, Ajith J, Basanth A, Jothydev K, Chandran B, S. S, Jothydev S. ADA, 81ST Scientific Sessions, Virtual, June 25-29, 2021. 853-P
Rediscovering The Power Of Telemedicine (DTMS®) In The Covid Era.
Kesavadev J, Saboo B, Shankar A, Krishnan G, Ashok A, Ajith J, Manoj A, S. S, Basanth A, Jyogesh S, Jothydev S. Advanced Technologies & Treatments for Diabetes, 14th International Conference, Virtual, June 2021.
Using Telemedicine and remote monitoring for diabetes during COVID-19: The Indian experience.
Advanced Technologies & Treatments for Diabetes, 14th International Conference, Virtual, June 2021. Invited Lecture- Dr.Jothydev Kesavadev.
A 2020 Update On Diabetes Technologies With Emphasis On Telemedicine During COVID-19.
Kesavadev J. Kerala Medical Journal. Vol 12: issue 3;Jul- Sept 2020: 112-115.
Harnessing the Possibilities of Telemedicine for Consultations in COVID
Crisis.Kesavadev J. Int J Diab May 2020;1-6.
Preventing diabetes complications with telemedicine - Insights gained from a real-world 20 year follow-up data
Oral presentation-.Kesavadev J, Shankar A, Ashok A. D, Krishnan G, Ajai N. A, Sanal G, Ajith J, Jayanthi S, Ramachandran L, Jothydev S.: Presenter: Ms.Gopika Krishnan. Oct 2018.
Are Complications Preventable with Periodic Education via Telemedicine? A Study of 414 Compliant T2D Patients Followed Up for 19 Years.
Kesavadev J, Shankar A, David A, Krishnan G, Ajai N. A, Sanal G,Ajith J, Jayanthi S, Ramachandran L, Jothydev S.Diabetes Jul 2018, 67 (Supplement 1) 685-P; DOI: 10.2337/db18-685-P.
Cost effective customisation of targets: Outcomes after 12 years of telemedicine in 853 patients with type 2 diabetes.
Kesavadev J, Shankar A, David A, Sanal G, Lally J, Krishnan G, Jothydev S. IDF Congress, Vancouver, British Columbia, Canada, Nov-Dec, 2015.
Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy.
Kesavadev J, Saboo B, Shankar A, Krishnan G, Jothydev S. Indian J Endocrinol Metab. Nov- Dec 2015. 19(6). 764–769.
Continuous customized education via telemedicine: outcome data of events over 8 years.
Kesavadev J, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S. IDF Congress, Melbourne, Australia, Dec, 2013.
Safety and Efficacy of Protaminated aspart Integrated with Telemedicine in Reducing A1c.
Invited lecture - Dr. Arun Shankar. 41st Annual Meeting of Research Society for the study of Diabetes in India, Delhi. Nov 2013.
C-peptide levels not affected by duration of diabetes in a telemedicine based long-term follow up programme.
Krishnan G, Pillai P. S, Shankar A, Jothydev S, Kesavadev J. Diabetologia. Sep 2013;56 Suppl 1:1-566.
Superiority of a Telemedicine Based Counselling in Ensuring Multi Drug Compliance in T2D.
Kesavadev J, Shankar A, Gopalakrishnan G, Lally J, Sanal G, Jothydev S. Diabetes Jun 2013, 62 (Supplement 1) 698-P; DOI: 10.2337/db13- 698-P.
Role of Telemedicine in treating diabetes.
Invited lecture - Dr.Jothydev Kesavadev. World Congress of Diabetes India, Kochi. Apr 2013.
Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus - a retrospective study.
Kesavadev J, Shankar A, Pillai P. B. S, Krishnan G, Jothydev S. Diabetes Technol Ther. Sep 2012. 14(9). 772-776.
Geographical location and effectiveness of a simple telemedicine program (DTMS®) in diabetes.
Kesavadev J, Pillai P. B. S, Shankar A, Gopalakrishnan G, Lally J, Jothydev S. Diabetes Technol Ther. Feb 2012. 14(19).
A1c, BP and LDL Goals - Successful Use of Telemedicine (DTMS®) in 1000 Compliant T2DM Subjects over 6 Months.
Kesavadev J, Babu P, Pillai S, Shankar A, Dinkar G, Lally J, Sanal G, Gopalakrishnan G, Jothydev S.Diabetes Jun 2011, 60 (Supplement 1) 229- OR; DOI: 10.2337/db11- 229- OR.
Our Hospital & Research Branches
Accessible, world-class comprehensive diabetes care and clinical research across 5 strategic locations.